USA — GE HealthCare, a leading medical technology company, has received FDA approval for its CARESCAPE Canvas patient monitoring platform.
The platform, which is a FlexAcutity solution, is equipped with smart parameter technology that can be used for patients at all levels of acuity.
This innovative solution offers flexibility and standardization by leveraging micromodules that connect with medical USB technology, making it easy to scale up and scale down monitoring capabilities based on the needs of each patient.
According to Neal Sandy, GE HealthCare’s monitoring solutions general manager, this new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient.
The platform offers effective care by allowing the simple connection or disconnection of cables provided for different configurations, enabling monitoring devices to be rapidly redeployed across the hospital enterprise.
This ensures that patients receive the right care, at the right time, from the right clinician.
Moreover, the CARESCAPE Canvas platform is equipped with advanced software and interchangeable frames, making it easy to redeploy monitoring devices across the hospital enterprise.
The platform’s flexibility and scalability make it a valuable tool for hospitals looking to optimize their patient monitoring capabilities.
GE HealthCare has revealed that it has conducted thorough development and testing of its new CARESCAPE Canvas bedside monitoring device.
The company has ensured that the device is not only compatible with current devices in the market, but also with previous versions in the ecosystem, offering healthcare systems the opportunity to upgrade to the newest patient monitoring capabilities at their own pace.
This backward compatibility is a significant advantage for healthcare providers, as it enables them to use the latest monitoring technology without the need for a complete overhaul of their existing monitoring infrastructure.
The CARESCAPE Canvas monitoring platform is equipped with smart parameter technology that can be used for patients at all levels of acuity.
It can be easily tailored for each patient, providing a flexible and standardized approach to patient monitoring.
The platform has been developed with a focus on sustainability and efficiency, with the company stating that it uses 25% less energy than previous versions and models.
Furthermore, GE HealthCare has reduced packaging volume by 53% and packaging weight by 48% compared to earlier versions, thereby reducing the environmental impact of the product.
GE HealthCare has also revealed that it manufactures its CARESCAPE Canvas monitors at its Helsinki site, using 100% renewable wind electricity.
This commitment to sustainability is a significant step forward in the medical technology industry, as it demonstrates the potential for manufacturers to adopt renewable energy sources to produce their products.
In June 2020, the company secured regulatory approval for the use of CARESCAPE Canvas in the European Union (EU).
With the recent approval from the US Food and Drug Administration (FDA), GE HealthCare is now poised to introduce its new monitoring ecosystem to the US market, providing healthcare providers with a flexible and sustainable patient monitoring solution.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
